Latest News

Deals this week: Kuros Biosciences, Suda, ProLynx

Swiss-based biotechnology company Kuros Biosciences intends to raise funds through the rights offering of shares of its common stock to raise between Sfr20.15m ($20.68m) and Sfr25m...

Deals this week: Kuros Biosciences, Suda, ProLynx

Eli Lilly completes expansion of San Diego biotechnology centre in US

US-based pharmaceutical company Eli Lilly has completed the $90m expansion of its biotechnology centre in San Diego,...

Eli Lilly completes expansion of San Diego biotechnology centre in US

M&As this week: Pamplona Capital Management, Spherix, Quantum Hi-Tech China Biological

UK-based private equity company Pamplona Capital Management has agreed to acquire Parexel International Corporation by acquiring the entire outstanding shares of the company in an...

M&As this week: Pamplona Capital Management, Spherix, Quantum Hi-Tech China Biological

Seqirus develops cell-based influenza vaccine at Holly Springs facility in US

Seqirus develops cell-based influenza vaccine at Holly Springs facility in US

Shire receives FDA approval for Mydayis to treat attention deficit hyperactivity disorder

Biotechnology company Shire has received the US Food and Drug Administration (FDA) approval for Mydayis (mixed salts of a single-entity amphetamine product) for the treatment of attention...

Shire receives FDA approval for Mydayis to treat attention deficit hyperactivity disorder

Therachon’s TA-46 receives FDA and EMA orphan drug designation for achondroplasia

Therachon’s TA-46 receives FDA and EMA orphan drug designation for achondroplasia

India's Glenmark signs license agreement for APC Therapeutics’ small molecule oncology compound

India-based Glenmark Pharmaceuticals has entered a licensing agreement with US company APC Therapeutics for exclusive rights to a small molecule, oncology compound based on antigen presenting...

India's Glenmark signs license agreement for APC Therapeutics’ small molecule oncology compound

Scientists discover new type of immune cell to guide immunotherapy for lung cancer

Scientists discover new type of immune cell to guide immunotherapy for lung cancer

Axis Biotec to begin construction on biopharmaceutical lab and manufacturing facility in Brazil

Axis Biotec Brasil is set to begin construction work on a new biopharmaceutical laboratory and pilot production facility in Rio de...

Axis Biotec to begin construction on biopharmaceutical lab and manufacturing facility in Brazil

Swissmedic accepts review of Takeda and TiGenix’s file on Cx601

The Swiss Agency for Therapeutic Products (Swissmedic) has accepted a review of Takeda and TiGenix’s file on investigational compound Cx601 for the treatment of complex perianal fistulas...

Swissmedic accepts review of Takeda and TiGenix’s file on Cx601

EC approves Sandoz’s Rixathon for blood cancer and immunological diseases

EC approves Sandoz’s Rixathon for blood cancer and immunological diseases

Bristol-Myers Squibb to sell APIs manufacturing facility in Ireland

Bristol-Myers Squibb (BMS) has signed a definitive purchase agreement to divest its small-molecule active pharmaceutical ingredient production facility in Swords, Ireland, to South Korean firm...

Bristol-Myers Squibb to sell APIs manufacturing facility in Ireland

Roche, Pfizer and Aspen under investigation over cancer drug pricing

The Competition Commission of South Africa has initiated separate investigations against three global pharmaceutical companies over suspected excessive pricing of cancer...

Roche, Pfizer and Aspen under investigation over cancer drug pricing

NHS England approves Kadcyla for routine use on NHS

NHS England has signed an agreement with Roche, which also received backing from NICE, to make the breast cancer drug Kadcyla available for routine use on the...

NHS England approves Kadcyla for routine use on NHS

J&J completes Actelion acquisition for $30bn

Johnson & Johnson (J&J) has completed the acquisition of Actelion Pharmaceuticals for approximately $30bn in an all-cash transaction through its Swiss subsidiary Janssen...

J&J completes Actelion acquisition for $30bn

UK NICE recommends Janssen’s Ustekinumab treatment for Crohn’s disease

UK NICE recommends Janssen’s Ustekinumab treatment for Crohn’s disease

Deals this week: Carma Therapeutics, Vectorite Biomedica, Loxo Oncology

Cellular immunotherapies developer Carma Theraputics has completed a venture financing round co-led by AbbVie Biotech Ventures and HealthCap in order to raise funds required to advance...

Deals this week: Carma Therapeutics, Vectorite Biomedica, Loxo Oncology

Eco Petroleum acquires Immunotech Laboratories

US-based firm Eco Petroleum Solutions has completed the acquisition of drug development company Immunotech Laboratories in a share exchange...

Eco Petroleum acquires Immunotech Laboratories

Integral Molecular begins immuno-oncology therapeutic targets discovery

Integral Molecular begins immuno-oncology therapeutic targets discovery

NIH and UNR Med researchers use unsuccessful cancer therapy to treat DMD

NIH and UNR Med researchers use unsuccessful cancer therapy to treat DMD

AbCellera and Teva expand research collaboration for new antibodies

Canadian biotechnology company AbCellera Biologics has entered a new therapeutic antibody discovery collaboration with Israeli-based Teva Pharmaceutical Industries to discover new...

AbCellera and Teva expand research collaboration for new antibodies
cachename:Newscachekey:rd-1665407042_1857678299_rd-488908060_1460672566_rd1460672566_371857150_ap1460672566_1857678299_946450448